Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

RESPARK - Brain Q for Chronic Stroke

NCT: NCT07095920 · RECRUITING

NCT IDNCT07095920
StatusRECRUITING
Start Date2025-08-27
Completion2026-12

Brief Summary

This trial tests a promising new intervention to promote post-stroke neural reorganization and functional recovery. The Q Therapeutic (BQ 3.0) is a wearable medical system that produces and delivers non-invasive, extremely-low-intensity and low-frequency, frequency-tuned electromagnetic fields in order to stimulate neuronal networks with the aim of reducing disability and promoting neurorecovery. This trial is a prospective, single-arm, open-label, single center clinical trial designed to evaluate the safety, feasibility, and efficacy of the Q Therapeutic (BQ 3.0) System in the rehabilitation of people with chronic stroke.

Frequently Asked Questions

What is RESPARK - Brain Q for Chronic Stroke?

RESPARK - Brain Q for Chronic Stroke is a clinical trial registered under NCT07095920. Current status: RECRUITING.

What is the status of NCT07095920?

The current status of NCT07095920 (RESPARK - Brain Q for Chronic Stroke) is: RECRUITING.

When did RESPARK - Brain Q for Chronic Stroke start?

RESPARK - Brain Q for Chronic Stroke started on 2025-08-27.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.